Effect of EDTA with porous balloon on calcified lesion : An atherosclerotic cadaver study
© 2024 Wiley Periodicals LLC..
BACKGROUND: Ethylene diamine tetra-acetic acid (EDTA) is a chelating agent used to dissolve calcium deposits but evidence in decalcifying atherosclerotic lesions is limited.
AIMS: We assessed the feasibility and efficacy of EDTA delivered via porous balloon to target calcified lesions in cadaveric below-the-knee (BTK) arteries.
METHODS: Using porcine carotid arteries, EDTA concentration was measured in the arterial wall and outside the artery at the 0-, 0.5-, 4-, and 24-h circulation after the injection through a porous balloon. In cadaver BTK samples, the proximal and distal anterior tibial artery (ATA) and distal posterior tibial artery (PTA) were studied. EDTA-2Na/H2O or EDTA-3Na/H2O were administrated using a porous balloon, then circulated for 6 h for EDTA-3Na/H2O and 24 h for EDTA-2Na/H2O and EDTA-3Na/H2O. Micro-CT imaging of the artery segments before and after the circulation and cross-sectional analyses were performed to evaluate calcium burden.
RESULTS: In the porcine carotid study, EDTA was delivered through a porous balloon present in the arterial wall and was retained there for 24 h. In BTK arteries, cross-sectional analyses of micro-CT revealed a significant decrease in the calcium area in the distal ATA segment under 24-h circulation with EDTA-2Na/H2O and in the distal ATA segment under 24-h circulation with EDTA-3Na/H2O. The proximal ATA segment under 6-h circulation with EDTA-3Na/H2O showed no significant change in any parameters of calcium CONCLUSION: EDTA-3Na/H2O or EDTA-2Na/H2O with longer circulation times resulted in greater calcium reduction in atherosclerotic lesion. EDTA may have a potential therapeutic option for the treatment of atherosclerotic calcified lesions.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:103 |
---|---|
Enthalten in: |
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions - 103(2024), 6 vom: 25. Apr., Seite 972-981 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kawai, Kenji [VerfasserIn] |
---|
Links: |
---|
Themen: |
9G34HU7RV0 |
---|
Anmerkungen: |
Date Completed 26.04.2024 Date Revised 26.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/ccd.31052 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM37095792X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM37095792X | ||
003 | DE-627 | ||
005 | 20240426234250.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240412s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/ccd.31052 |2 doi | |
028 | 5 | 2 | |a pubmed24n1388.xml |
035 | |a (DE-627)NLM37095792X | ||
035 | |a (NLM)38606477 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kawai, Kenji |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effect of EDTA with porous balloon on calcified lesion |b An atherosclerotic cadaver study |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.04.2024 | ||
500 | |a Date Revised 26.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024 Wiley Periodicals LLC. | ||
520 | |a BACKGROUND: Ethylene diamine tetra-acetic acid (EDTA) is a chelating agent used to dissolve calcium deposits but evidence in decalcifying atherosclerotic lesions is limited | ||
520 | |a AIMS: We assessed the feasibility and efficacy of EDTA delivered via porous balloon to target calcified lesions in cadaveric below-the-knee (BTK) arteries | ||
520 | |a METHODS: Using porcine carotid arteries, EDTA concentration was measured in the arterial wall and outside the artery at the 0-, 0.5-, 4-, and 24-h circulation after the injection through a porous balloon. In cadaver BTK samples, the proximal and distal anterior tibial artery (ATA) and distal posterior tibial artery (PTA) were studied. EDTA-2Na/H2O or EDTA-3Na/H2O were administrated using a porous balloon, then circulated for 6 h for EDTA-3Na/H2O and 24 h for EDTA-2Na/H2O and EDTA-3Na/H2O. Micro-CT imaging of the artery segments before and after the circulation and cross-sectional analyses were performed to evaluate calcium burden | ||
520 | |a RESULTS: In the porcine carotid study, EDTA was delivered through a porous balloon present in the arterial wall and was retained there for 24 h. In BTK arteries, cross-sectional analyses of micro-CT revealed a significant decrease in the calcium area in the distal ATA segment under 24-h circulation with EDTA-2Na/H2O and in the distal ATA segment under 24-h circulation with EDTA-3Na/H2O. The proximal ATA segment under 6-h circulation with EDTA-3Na/H2O showed no significant change in any parameters of calcium CONCLUSION: EDTA-3Na/H2O or EDTA-2Na/H2O with longer circulation times resulted in greater calcium reduction in atherosclerotic lesion. EDTA may have a potential therapeutic option for the treatment of atherosclerotic calcified lesions | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a atherosclerosis | |
650 | 4 | |a below‐the‐knee | |
650 | 4 | |a calcification | |
650 | 4 | |a micro‐CT | |
650 | 7 | |a Edetic Acid |2 NLM | |
650 | 7 | |a 9G34HU7RV0 |2 NLM | |
650 | 7 | |a Calcium Chelating Agents |2 NLM | |
700 | 1 | |a Madra, Anna |e verfasserin |4 aut | |
700 | 1 | |a Kawakami, Rika |e verfasserin |4 aut | |
700 | 1 | |a Sato, Yu |e verfasserin |4 aut | |
700 | 1 | |a Konishi, Takao |e verfasserin |4 aut | |
700 | 1 | |a Shiraki, Tatsuya |e verfasserin |4 aut | |
700 | 1 | |a Sekimoto, Teruo |e verfasserin |4 aut | |
700 | 1 | |a Tanaka, Takamasa |e verfasserin |4 aut | |
700 | 1 | |a Virmani, Renu |e verfasserin |4 aut | |
700 | 1 | |a Finn, Aloke V |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions |d 1999 |g 103(2024), 6 vom: 25. Apr., Seite 972-981 |w (DE-627)NLM101487487 |x 1522-726X |7 nnns |
773 | 1 | 8 | |g volume:103 |g year:2024 |g number:6 |g day:25 |g month:04 |g pages:972-981 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/ccd.31052 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 103 |j 2024 |e 6 |b 25 |c 04 |h 972-981 |